For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...
A new analysis shows that anti-inflammatory medications may help reduce symptoms for a subset of people with depression who ...
The move towards a higher threshold for showing efficacy for new CAR-Ts comes after the FDA loosened the requirements for ...
2don MSN
A subset of patients with depression could benefit from anti-inflammatory treatment, study finds
At any given moment in time, more than 400 million individuals worldwide are battling depression. The antidepressant ...
Adults with type 2 diabetes or overweight or obesity who received GLP-1s do not have increased risk for obesity-related ...
Pegozafermin is a long-acting glycopegylated (pegylated with the use of site-specific glycosyltransferases) fibroblast growth factor 21 (FGF21) analogue in development for the treatment of ...
Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback